scholarly article | Q13442814 |
P2093 | author name string | A M Gómez | |
K L Rosenthal | |||
F M Smaill | |||
P2860 | cites work | HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease | Q28267375 |
Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization | Q33567984 | ||
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual | Q34185306 | ||
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS | Q34250436 | ||
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 | ||
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication | Q35262596 | ||
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes | Q36356023 | ||
Cytotoxic T lymphocytes against HIV | Q36578424 | ||
Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism | Q36820948 | ||
Comparable sensitivities for detection of human immunodeficiency virus by sensitive reverse transcriptase and antigen capture enzyme-linked immunosorbent assays | Q37144165 | ||
Variable and conserved neutralization antigens of human immunodeficiency virus | Q38891686 | ||
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness | Q39576364 | ||
Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture. | Q40209735 | ||
AIDS virus-specific cytotoxic T lymphocytes in lung disorders | Q41447927 | ||
In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha | Q41707962 | ||
Activation of complement on the surface of cells infected by human immunodeficiency virus | Q41744013 | ||
Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys | Q41757062 | ||
CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor | Q43730414 | ||
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells | Q43875706 | ||
A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. | Q44141073 | ||
Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees | Q44246260 | ||
Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus | Q44527640 | ||
CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture | Q44905194 | ||
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides | Q45151315 | ||
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages | Q45831153 | ||
Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes | Q45839300 | ||
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells | Q45842647 | ||
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity | Q45853477 | ||
HIV replication can be blocked by recombinant human interferon beta. | Q46031119 | ||
CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals | Q46442421 | ||
CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses | Q46494799 | ||
HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. | Q52848179 | ||
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. | Q54478001 | ||
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. | Q55244180 | ||
Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones | Q58991727 | ||
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS | Q59057787 | ||
Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals | Q68943219 | ||
Evaluation of natural killer cell activity in patients with persistent generalized lymphadenopathy and acquired immunodeficiency syndrome | Q69869521 | ||
An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status | Q70489799 | ||
Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals | Q72231557 | ||
P433 | issue | 1 | |
P304 | page(s) | 68-75 | |
P577 | publication date | 1994-07-01 | |
P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
P1476 | title | Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease | |
P478 | volume | 97 |